# Papers

Paper describing the transcripts of fusions: 

Zucman, J. et al. Combinatorial generation of variable
fusion proteins in the Ewing family of tumours. EMBO J.
12, 4481–4487 (1993).

Riggi, N. et al. EWS-FLI1 utilizes divergent chromatin
remodeling mechanisms to directly activate or repress
enhancer elements in Ewing sarcoma. Cancer Cell 26,
668–681 (2014).

Tomazou, E. M. et al. Epigenome mapping reveals
distinct modes of gene regulation and widespread
enhancer reprogramming by the oncogenic fusion
protein EWS-FLI1. Cell Rep. 10, 1082–1095 (2015).

Sheffield, N. C. et al. DNA methylation heterogeneity
defines a disease spectrum in Ewing sarcoma.
Nat. Med. 23, 386–395 (2017).

Gorthi, A. et al. EWS–FLI1 increases transcription to
cause R-loops and block BRCA1 repair in Ewing
sarcoma. Nature 555, 387–391 (2018).

Johnson, K. M. et al. Role for the EWS domain of EWS/
FLI in binding GGAA-microsatellites required for Ewing
sarcoma anchorage independent growth. Proc. Natl
Acad. Sci. USA 114, 9870–9875 (2017).

Boulay, G. et al. Cancer-specific retargeting of BAF
complexes by a prion-like domain. Cell 171, 163–178
(2017).
